Fate Therapeutics Inc (FATE)
2.065
-0.16
(-6.98%)
USD |
NASDAQ |
Nov 21, 16:00
2.07
0.00 (0.00%)
After-Hours: 19:56
Fate Therapeutics Market Cap: 235.19M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 252.85M |
| November 19, 2024 | 248.29M |
| November 18, 2024 | 258.54M |
| November 15, 2024 | 230.07M |
| November 14, 2024 | 236.90M |
| November 13, 2024 | 247.15M |
| November 12, 2024 | 271.07M |
| November 11, 2024 | 291.57M |
| November 08, 2024 | 275.62M |
| November 07, 2024 | 290.43M |
| November 06, 2024 | 317.77M |
| November 05, 2024 | 305.24M |
| November 04, 2024 | 314.32M |
| November 01, 2024 | 276.74M |
| October 31, 2024 | 269.91M |
| October 30, 2024 | 283.57M |
| October 29, 2024 | 309.77M |
| October 28, 2024 | 326.85M |
| October 25, 2024 | 301.80M |
| October 24, 2024 | 320.02M |
| October 23, 2024 | 345.07M |
| October 22, 2024 | 363.29M |
| October 21, 2024 | 358.74M |
| October 18, 2024 | 367.85M |
| October 17, 2024 | 366.71M |
| Date | Value |
|---|---|
| October 16, 2024 | 365.57M |
| October 15, 2024 | 347.35M |
| October 14, 2024 | 347.35M |
| October 11, 2024 | 351.90M |
| October 10, 2024 | 334.82M |
| October 09, 2024 | 342.79M |
| October 08, 2024 | 349.63M |
| October 07, 2024 | 347.35M |
| October 04, 2024 | 366.71M |
| October 03, 2024 | 355.32M |
| October 02, 2024 | 365.57M |
| October 01, 2024 | 381.51M |
| September 30, 2024 | 398.60M |
| September 27, 2024 | 406.54M |
| September 26, 2024 | 398.57M |
| September 25, 2024 | 392.88M |
| September 24, 2024 | 392.88M |
| September 23, 2024 | 414.52M |
| September 20, 2024 | 440.71M |
| September 19, 2024 | 455.51M |
| September 18, 2024 | 441.85M |
| September 17, 2024 | 455.51M |
| September 16, 2024 | 450.96M |
| September 13, 2024 | 457.79M |
| September 12, 2024 | 425.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
162.67M
Minimum
Oct 27 2023
10.90B
Maximum
Jan 14 2021
2.856B
Average
2.128B
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.561M |
| Oragenics Inc | 3.301M |
Market Cap Related Metrics
| PS Ratio | 16.70 |
| Price to Book Value | 0.6491 |
| Price | 2.065 |
| Earnings Yield | -79.90% |